Filing metadata

Accession number
0001628280-22-019118
Form type
Form 3
Filer
Aurinia Pharmaceuticals Inc.
CIK
CIK 1600620
Filed
Jul 19, 2022
Reporting period
Jul 18, 2022
Description
Initial ownership

Explore SEC Filings Hub